Request Sample

Global High Content Screening Market

June 25, 2019

Global High Content Screening Market, By Type (Instruments (Cell Imaging and Analysis Systems and Flow Cytometers), Consumables (Reagents & Assay Kits, Microplates and Other Consumables), Software , and Services and Accessories), By Application (Primary and secondary screening, Target identification and validation, Toxicity studies, Compound profiling. and Others), By End User (Pharmaceutical industry, Biotechnology Industry, Educational Institutions, Government Organizations, and Contract Research Organizations (CROs)), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR612      
Pages :199 Pages
Format :   PPT Format   PDF Format

The global high content screening market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and it is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). High content screening (HCS), which is also known as high content analysis, is a technique that is mostly being used in biological research and drug innovations to recognize elements, like micro molecules, peptides, or RNA that modify the phenotype of a cell in an expected approach. HCS is associated with high throughput screening (HTS), which supports thousands of compounds that are being tested simultaneously for their activity in one biological assay or even more than that, but contains assays of more complicated cellular phenotypes as result. Rising government investment in the healthcare sector drives the market of high content screening market.

Table 1. Global High Content Screening Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Type)

Instruments (Cell Imaging and Analysis Systems and Flow Cytometers), Consumables (Reagents & Assay Kits, Microplates and Other Consumables), Software , and Services and Accessories

Market Segmentation (By Application)

Primary and secondary screening, Target identification and validation, Toxicity studies, Compound profiling. and Others

Market Segmentation (By End User)

Pharmaceutical industry, Biotechnology Industry, Educational Institutions, Government Organizations, and Contract Research Organizations (CROs)

Regions Covered

North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa

Key Players Coverage

 Becton, Dickinson and Company (BD), Thermo Fisher Scientific, GE Healthcare, Olympus Corporation, PerkinElmer Inc., Thorlabs Inc., Cell Signaling Technology, Merck KGaA, Yokogawa Electric Corporation,and Genedata AG, , amomg others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Increasing investment in research and development (R&D) and increasing occurrence of diseases, like COVID-19, Ebola, MERS, and Zika contribute to surge in the market demand for HCS in the forecast period, as HCS is a powerful tool to help fight diseases by developing new therapeutics and vaccines. Thus, these factors contribute to surge the demand of HCS in the market and hence drive the high content screening market, globally. For instance, in June 2020, with the help of high content screening, Glenmark Pharmaceuticals Ltd announced the launch of an antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price of nearly US$ 1.37 per tablet.

However, the shortage of trained and skilled professional and rising cost of content screening equipment act as restraints for the growth of the market. A primary cell-based screen of 100,000 compounds may cost more than $25,000.

Figure 1. PORTER’S Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is the major shareholder of high content screening market because of increasing technological advancements, availability of skilled professionals, and huge expenditure in healthcare sector. For instance, in December 2019, Olympus declared the release of the scan R high-content screening (HCS) station, which is a cell imaging solution that employs the use of artificial intelligence (AI) to allow next-generation biological research in the U.S. It merges the modularity and elasticity of a microscope-based setup with the automation, pace, throughput, and reproducibility of an HCS station.

Moreover, Europe is also expected to show vital growth in the foreseen future owing to increasing awareness among the citizens in terms of healthcare expenditure.

Figure 2. Regional Analysis

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in the global high content screening market include: Becton, Dickinson and Company (BD), Thermo Fisher Scientific, GE Healthcare, Olympus Corporation, PerkinElmer Inc., Thorlabs Inc., Cell Signaling Technology, Merck KGaA, Yokogawa Electric Corporation,and Genedata AG, , amomg others.

The key market players have acquired various schemes of product development, investment in R&D and partnerships to retain their position in the market. For instance, in December 2019, GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) stepped into a strategic research & development and distribution partnership that sets out to personalize tissue revival. The amalgamation of IN Cell Analyzer and BioAssemblyBot systems technologies will implant cellular-level assessments into the 3D-bioprinting workflow which are being employ to generate model for human tissues. [6] Hence, by collaborating this flexibility of the BioAssemblyBot with the image quality and speed of the IN Cell Analyzer 6500 HS confocal screening platform, the probability of automating high content screening in 3D models can become a actuality.”

Moreover, in February 2019, Ncardia declared the release of DiscoveryHIT drug screening platform which assists the researchers to diagnose human ailments early in the process of drug discovery. The objective of this discovery was to assist the patient with better medication.

Figure 3. Market Share of Key Players, 2019

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

 

By Type

  • Instruments
  • Cell imaging systems,
  • Flow cytometers
    • Cell Analyzers
    • Cell Sorters
  • Consumables
  • Reagents and Assay kits
  • Microplates
  • Other Consumables
  • Software
  • Service and Accessories

By Application

  • Primary and Secondary Screening
  • Target Identification and Validation
  • Toxicity Studies
  • Compound Profiling
  • Others

By End User

  • Pharmaceutical industry
  • Biotechnology industry
  • Educational institutions
  • Government organizations
  • Contract research organizations (CROs)

By Region                            

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global high content screening market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global high content screening market?
  • What key factors are expected to increase the demand for high content screening market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global high content screening market?
  • What is the total market value (US$ Mn) generated in global high content screening market by type in 2019 and what are the forecasts by 2025?
  • Which application is expected to dominate the high content screening market in the coming years?
  • Which end user contributes highest CAGR (%) to the high content screening market?
  • What was the total revenue generated by the global high content screening market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the high content screening diagnostics market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the high content screening market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.